IMARC Group, a leading market research company, has recently releases report titled “Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global amniotic membrane market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the amniotic membrane market?
The global amniotic membrane market size reached US$ 1.4 billion in 2022 and the market to reach US$ 2.4 Bn by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.
What is amniotic membrane?
The amniotic membrane (AM), or amnion, refers to the thin innermost layer of the placenta. It comprises an epithelial monolayer, acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity that is filled with amniotic liquid. AM is used as a substrate to regrow the deficient epithelium and ensure effective drug delivery as a nano-reservoir. Additionally, it exhibits anti-inflammatory, wound-healing, anti-bacterial, anti-angiogenic, and pro-apoptotic properties. Consequently, AM is utilized as regenerative medicine, graft, and dressing for wounds in different surgical subspecialties to allow faster recovery and protection against infections.
Get the Sample Report: https://www.imarcgroup.com/amniotic-membrane-market/requestsample
What are the growth prospects and trends in the amniotic membrane industry?
The increasing instances of amniotic membrane transplantation, owing to the rising awareness regarding its multiple benefits and the escalating demand for tissue-based medicinal products, are primarily driving the market growth. Moreover, the extensive uptake of AM in ophthalmic surgeries to reconstruct the ocular surface and promote healing in persistent epithelial defect cases is impelling the market growth. As AM possesses anti-cancer properties, it is used in oncology to prevent the distribution of nutrients and oxygen to cancer cells, which is acting as another growth-inducing factor.
Additionally, the widespread adoption of the product in the healthcare sector to heal chronic burn wounds and reduce pain, infection, sepsis, and discomfort is propelling the market growth. Besides this, the growing need for amniotic allografts and the advent of human acellular amniotic membrane (HAAM) implantation and human amniotic membranes (hAM) for cardiac tissue regeneration are positively impacting the market.
Who are the key players operating in the industry?
The report covers the major market players including:
Amniotic Membrane Key Companies:
- Amnio Technology LLC
- Amniox Medical Inc. (TissueTech Inc.)
- Genesis Biologics
- Human Regenerative Technologies LLC
- Integra LifeSciences Holdings Corporation
- Katena Products Inc.
- MiMedx Group
- Next Biosciences
- Skye Biologics Holdings LLC
- Smith & Nephew plc
- Surgenex LLC
- Ventris Medical LLC
- Wright Medical Group N.V. (Stryker B.V.)
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Breakup by Application:
- Surgical Wounds
- Ophthalmology
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:134 N 4th St.
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com